Weiping Han (W Han)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 16

Top Topics

Diabetic Nephropathy

Top Venues

EMBO molecular medicine

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Wing Yan So, Weiping Han
Gene therapy targeting key beta cell regulators as a potential intervention for diabetes. EMBO molecular medicine 16 (7) (2024)
Wing Yan So, Weiping Han
Gene therapy targeting key beta cell regulators as a potential intervention for diabetes. EMBO molecular medicine 16 (7) (2024)
Wing Yan So, Weiping Han
Gene therapy targeting key beta cell regulators as a potential intervention for diabetes. EMBO molecular medicine (2024)
Wing Yan So, Weiping Han
Gene therapy targeting key beta cell regulators as a potential intervention for diabetes. EMBO molecular medicine 16 (7) (2024)
Wing Yan So, Yilie Liao, Wai Nam Liu, Guy A Rutter, Weiping Han
Paired box 6 gene delivery preserves beta cells and improves islet transplantation efficacy. EMBO molecular medicine (2023)
Yuxiao Yao, Weiping Han
Proline Metabolism in Neurological and Psychiatric Disorders. Molecules and cells 45 (11) (2022)
Wing Yan So, Wai Nam Liu, Adrian Kee Keong Teo, Guy A Rutter, Weiping Han
Paired box 6 programs essential exocytotic genes in the regulation of glucose-stimulated insulin secretion and glucose homeostasis. Science translational medicine 13 (600) (2021)
Zhaobing Ding, Russell E Ericksen, Qian Yi Lee, Weiping Han
Reprogramming of mitochondrial proline metabolism promotes liver tumorigenesis. Amino acids 53 (12) (2021)
H Y Angeline Tan, M F Michelle Sim, Shi-Xiong Tan, Yvonne Ng, Sin Yee Gan, Hongyu Li, Suat Peng Neo, Jayantha Gunaratne, Feng Xu, Weiping Han
HOXC10 Suppresses Browning to Maintain White Adipocyte Identity. Diabetes 70 (8) (2021)
Hiu Yan Lam, Surendar Arumugam, Han-Gyu Bae, Cheng Chun Wang, Sangyong Jung, Ashley Lauren St John, Wanjin Hong, Weiping Han, Vinay Tergaonkar
ELKS1 controls mast cell degranulation by regulating the transcription of Stxbp2 and Syntaxin 4 via Kdm2b stabilization. Science advances 6 (31) (2020)
Jin Rong Ow, Matias J Caldez, Gözde Zafer, Juat Chin Foo, Hong Yu Li, Soumita Ghosh, Heike Wollmann, Amaury Cazenave-Gassiot, Chee Bing Ong, Markus R Wenk, Weiping Han, Hyung Won Choi, Philipp Kaldis
Remodeling of whole-body lipid metabolism and a diabetic-like phenotype caused by loss of CDK1 and hepatocyte division. eLife 9 (2020)
Jay Prakash Singh, Kevin Qian, Jeong-Sang Lee, Jinfeng Zhou, Xuemei Han, Bichen Zhang, Qunxiang Ong, Weiming Ni, Mingzuo Jiang, Hai-Bin Ruan, Min-Dian Li, Kaisi Zhang, Zhaobing Ding, Philip Lee, Hans-Guido Wendel, Jing Wu, Raimund I Herzog, Susan Kaech, Hans-Guido Wendel, John Yates Iii, Weiping Han, Robert S Sherwin, Yongzhan Nie, Xiaoyong Yang
O-GlcNAcase targets pyruvate kinase M2 to regulate tumor growth. Oncogene 39 (3) (2019)
Yong Chun Chong, Tau En Lim, Yanyun Fu, Eun Myoung Shin, Vinay Tergaonkar, Weiping Han
Indian Hedgehog links obesity to development of hepatocellular carcinoma. Oncogene 38 (12) (2018)
Yvonne Ng, Shi-Xiong Tan, Sook Yoong Chia, Hwee Yim Angeline Tan, Sin Yee Gun, Lei Sun, Wanjin Hong, Weiping Han
HOXC10 suppresses browning of white adipose tissues. Experimental & molecular medicine 49 (2) (2017)
Sofi G Julien, Sun-Yee Kim, Reinhard Brunmeir, Joanna R Sinnakannu, Xiaojia Ge, Hongyu Li, Wei Ma, Jadegoud Yaligar, Bhanu Prakash Kn, Sendhil S Velan, Pia V Röder, Qiongyi Zhang, Choon Kiat Sim, Jingyi Wu, Marta Garcia-Miralles, Mahmoud A Pouladi, Wei Xie, Craig McFarlane, Weiping Han, Feng Xu
Narciclasine attenuates diet-induced obesity by promoting oxidative metabolism in skeletal muscle. PLoS biology 15 (2) (2017)
J Huo, Y Ma, J-J Liu, Y S Ho, S Liu, L Y Soh, S Chen, S Xu, Weiping Han, A Hong, S C Lim, K-P Lam
Loss of Fas apoptosis inhibitory molecule leads to spontaneous obesity and hepatosteatosis. Cell death & disease 7 (2016)